Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Tät®II app for treating urgency and mixed urinary incontinence

Official title: Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence

Run by Umeå University · NCT07038811 · Data updated 2026-11-12

This project will test whether using the Tät®II app for 15 weeks helps women 18 and older who have urgency or mixed urinary incontinence after a doctor's assessment.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment60 (estimated)
SponsorUmeå University
Academic / other
Locations1 site (Östersund)
StatusRecruiting
StartedJune 12, 2025
Main results expectedJune 1, 2027
Study endsJune 1, 2027
Registry record updatedJune 26, 2025
Trial IDNCT07038811 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older with doctor-documented urgency or mixed urinary incontinence who can provide a recent medical record and consent to digital follow-up are ideal candidates.

Probably not a fit

Women who are pregnant, recently gave birth within six months, have painful urgency, difficulty emptying the bladder, visible blood in the urine, or need further urological investigation may not benefit from this app-based approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational implementation project invites women with doctor-diagnosed urgency or mixed urinary incontinence to use the Tät®II smartphone app for 15 weeks and complete online questionnaires at baseline, after treatment, and one year later. Participants are recruited via primary care waiting rooms, social media, and a research webpage, and eligibility is confirmed during a secure video meeting with the study team. Enrollment requires a recent medical record documenting the urinary incontinence diagnosis and absence of exclusion conditions such as pregnancy or recent childbirth. The study will monitor real-world feasibility of delivering first-line pelvic floor muscle and bladder training through the app across Sweden.

Why it matters

Potential benefit: If successful, this could give women an accessible home-based option to reduce urgency and mixed incontinence symptoms without extra clinic visits.

How similar studies have gone: Previous research on app- and home-based pelvic floor muscle training has shown symptom improvements for some types of urinary incontinence, though implementation after primary care is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female gender
* Age ≥18 years
* Symptoms of urgency urinary incontinence or mixed urinary incontinence
* Medical evaluation and documentation of urinary incontinence by ordinary doctor
* Signed informed consent

Exclusion Criteria:

* Pregnancy
* Childbirth in the last 6 months
* Painful urges
* Difficulties emptying the bladder
* Blood in urine
* Need of further investigation concerning the urinary incontinence, according to the clinical doctor

Where it's running

  • Region Jämtland Härjedalen
    Östersund, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.